High-Flow Nasal Cannula for Respiratory Support in Adult ICU Patients: A Systematic Review

Authors

  • Alaa Ahmed Alqattan Respiratory therapist Respiratory care services, Intensive Care Unit King Saud University Medical City (KSUMC) Saudi Arabia , Riyadh Author
  • Reem Dhafer Alahmari Respiratory therapist Respiratory care services, Intensive Care Unit King Saud University Medical City (KSUMC) Saudi Arabia , Riyadh Author
  • Waad Mohammed Hajib Respiratory therapist Respiratory care services, Intensive Care Unit King Saud University Medical City (KSUMC) Saudi Arabia , Riyadh Author
  • Zahra Anwar Almarhoon Respiratory therapist Respiratory care services, Intensive Care Unit King Saud University Medical City (KSUMC) Saudi Arabia , Riyadh Author
  • Yara Anwar Almutairy Respiratory therapist Respiratory care services, Intensive Care Unit King Saud University Medical City (KSUMC) Saudi Arabia , Riyadh Author
  • Lamya Dhaifallah Alnakhli Respiratory therapist Respiratory care services, Intensive Care Unit King Saud University Medical City (KSUMC) Saudi Arabia , Riyadh Author

DOI:

https://doi.org/10.65759/m0nxfy71

Keywords:

high flow nasal cannula, respiratory support, noninvasive ventilation, intensive care unit

Abstract

Background: High-flow nasal cannula (HFNC) is increasingly used for non-invasive respiratory support in adult ICU patients, mainly after extubation and in hypoxemic respiratory failure. Out study aim to evaluate the effectiveness of HFNC compared with conventional oxygen therapy, non-invasive ventilation (NIV), or non-invasive positive pressure ventilation in adult ICU patients requiring respiratory support. Methods: This systematic review followed PRISMA principles. We searched PubMed, Cochrane, Google Scholar, and other electronic databases for randomized controlled trials published between 2017 and 2025. Adult ICU studies comparing HFNC with conventional oxygen therapy, NIV, or non-invasive positive pressure ventilation were included. Overall, 466 records were identified, 421 remained after duplicate removal, 51 full texts were assessed, and 5 randomized controlled trials were included. Results: The included trials reported heterogeneous outcomes, including hospital length of stay, PaO2/FiO2 ratio, post-extubation vital signs, arterial blood gases, respiratory failure within 3 days after extubation, and 28-day mortality. HFNC associated with shorter hospital stay and fewer ICU readmissions in postoperative cardiac patients, improved oxygenation and reduced NIV use in severe hypoxemia after cardiac surgery, and provided comparable physiological  Conclusion: HFNC is effective respiratory support option in selected adult ICU populations, mainly for oxygenation, comfort, and some post-extubation outcomes.

References

1. McConville JF, Kress JP. Weaning Patients from the Ventilator. N Engl J Med. 2012 Dec 6;367(23):2233–9.

2. Esteban A, Frutos-Vivar F, Muriel A, Ferguson ND, Peñuelas O, Abraira V, et al. Evolution of Mortality over Time in Patients Receiving Mechanical Ventilation. Am J Respir Crit Care Med. 2013 Jul 15;188(2):220–30.

3. Thille AW, Richard JCM, Brochard L. The Decision to Extubate in the Intensive Care Unit. Am J Respir Crit Care Med. 2013 Jun 15;187(12):1294–302.

4. Papazian L, Corley A, Hess D, Fraser JF, Frat JP, Guitton C, et al. Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med. 2016 Sep 11;42(9):1336–49.

5. Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, et al. Nasal High-Flow versus Venturi Mask Oxygen Therapy after Extubation. Effects on Oxygenation, Comfort, and Clinical Outcome. Am J Respir Crit Care Med. 2014 Aug 1;190(3):282–8.

6. Rittayamai N, Tscheikuna J, Rujiwit P. High-Flow Nasal Cannula Versus Conventional Oxygen Therapy After Endotracheal Extubation: A Randomized Crossover Physiologic Study. Respir Care. 2014 Apr;59(4):485–90.

7. Riera J, Pérez P, Cortés J, Roca O, Masclans JR, Rello J. Effect of High-Flow Nasal Cannula and Body Position on End-Expiratory Lung Volume: A Cohort Study Using Electrical Impedance Tomography. Respir Care. 2013 Apr 5;58(4):589–96.

8. Parke RL, McGuinness SP. Pressures Delivered By Nasal High Flow Oxygen During All Phases of the Respiratory Cycle. Respir Care. 2013 Oct;58(10):1621–4.

9. Girault C, Breton L, Richard JC, Tamion F, Vandelet P, Aboab J, et al. Mechanical effects of airway humidification devices in difficult to wean patients*. Crit Care Med. 2003 May;31(5):1306–11.

10. McAllister DA, Wild SH, MacLay JD, Robson A, Newby DE, MacNee W, et al. Forced Expiratory Volume in One Second Predicts Length of Stay and In-Hospital Mortality in Patients Undergoing Cardiac Surgery: A Retrospective Cohort Study. Sun J, editor. PLoS One. 2013 May 28;8(5):e64565.

11. Dysart K, Miller TL, Wolfson MR, Shaffer TH. Research in high flow therapy: Mechanisms of action. Respir Med. 2009 Oct;103(10):1400–5.

12. Möller W, Feng S, Domanski U, Franke KJ, Celik G, Bartenstein P, et al. Nasal high flow reduces dead space. J Appl Physiol. 2017 Jan 1;122(1):191–7.

13. Williams R, Rankin N, Smith T, Galler D, Seakins P. Relationship between the humidity and temperature of inspired gas and the function of the airway mucosa. Crit Care Med. 1996 Nov;24(11):1920–9.

14. Hernández G, Vaquero C, González P, Subira C, Frutos-Vivar F, Rialp G, et al. Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on Reintubation in Low-Risk Patients. JAMA. 2016 Apr 5;315(13):1354.

15. Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure. N Engl J Med. 2015 Jun 4;372(23):2185–96.

16. Vourc’h M, Nicolet J, Volteau C, Caubert L, Chabbert C, Lepoivre T, et al. High-Flow Therapy by Nasal Cannulae Versus High-Flow Face Mask in Severe Hypoxemia After Cardiac Surgery: A Single-Center Randomized Controlled Study—The HEART FLOW Study. J Cardiothorac Vasc Anesth. 2020 Jan;34(1):157–65.

17. Stéphan F, Barrucand B, Petit P, Rézaiguia-Delclaux S, Médard A, Delannoy B, et al. High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic Surgery. JAMA. 2015 Jun 16;313(23):2331.

18. Parke RL, McGuinness SP, Eccleston ML. A Preliminary Randomized Controlled Trial to Assess Effectiveness of Nasal High-Flow Oxygen in Intensive Care Patients. Respir Care. 2011 Mar;56(3):265–70.

19. Fernandez R, Subira C, Frutos-Vivar F, Rialp G, Laborda C, Masclans JR, et al. High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non-hypercapnic patients: a randomized multicenter trial. Ann Intensive Care. 2017 Dec 2;7(1):47.

20. Thille AW, Boissier F, Ben Ghezala H, Razazi K, Mekontso-Dessap A, Brun-Buisson C. Risk Factors for and Prediction by Caregivers of Extubation Failure in ICU Patients. Crit Care Med. 2015 Mar;43(3):613–20.

21. Zochios V, Collier T, Blaudszun G, Butchart A, Earwaker M, Jones N, et al. The effect of high‐flow nasal oxygen on hospital length of stay in cardiac surgical patients at high risk for respiratory complications: a randomised controlled trial. Anaesthesia. 2018 Dec 18;73(12):1478–88.

22. Jing G, Li J, Hao D, Wang T, Sun Y, Tian H, et al. Comparison of high flow nasal cannula with noninvasive ventilation in chronic obstructive pulmonary disease patients with hypercapnia in preventing postextubation respiratory failure: A pilot randomized controlled trial. Res Nurs Health. 2019 Jun 18;42(3):217–25.

23. Azoulay E, Lemiale V, Mokart D, Nseir S, Argaud L, Pène F, et al. Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure. JAMA. 2018 Nov 27;320(20):2099.

Downloads

Published

2025-12-13